Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.

Y. Bécouarn, Marc Ychou, Michel Ducreux, +11

Journal of Clinical Oncology

Clinical Significance and Prognostic Value of CA72‐4 Compared with CEA and CA19‐9 in Patients with Gastric Cancer

Marc Ychou, Jacqueline Duffour, A. Kramar, +2

Disease Markers

Surgical OncologyEsophageal CancerCa72‐4 ComparedHealth SciencesGastrointestinal Oncology +13

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study

B Iacopetta, Antonio Russo, Viviana Bazan, +60

Annals of Oncology

Functional CategoriesTp53 MutationMedicineColorectal CancerPathology +7

MR Volumetric Measurement of Low Rectal Cancer Helps Predict Tumor Response and Outcome after Combined Chemotherapy and Radiation Therapy

Stéphanie Nougaret, Philippe Rouanet, Nicolas Molinari, +9

Radiology

Characterization of an adaptive immune response in microsatellite-instable colorectal cancer

Florence Boissière‐Michot, Gwendal Lazennec, Hélène Frugier, +9

OncoImmunology

Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer

Fran x E oise Bressolle, Jean Michel Joulia, Fr x E d x E ric Pinguet, +4

Cancer Chemotherapy and Pharmacology

MedicinePharmacologyColorectal CancerMetastatic Colorectal CancerOncology +4

Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen

Marc Ychou, Jacqueline Duffour, Andrew Kramar, +4

Cancer Chemotherapy and Pharmacology

OncologyGastrointestinal OncologyPharmacologyColorectal CancerDose Adaptation +5

Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid

Jean Michel Joulia, Frédéric Pinguet, Marc Ychou, +3

European Journal of Cancer

Gastrointestinal OncologyMedicineMetronomic TherapyPharmacologyColorectal Cancer +6

Five-year change in statistical designs of phase II trials published in leading cancer journals

Simon Thézenas, Jacqueline Duffour, Stéphane Culine, +1

European Journal of Cancer

Clinical Trial DesignMeta-analysisCancer JournalsMedicineStatistical Designs +10

Pharmacokinetics and pharmacodynamics of irinotecan and its metabolites from plasma and saliva data in patients with metastatic digestive cancer receiving Folfiri regimen

Sylvain Poujol, Françoise Bressolle, Jacqueline Duffour, +4

Cancer Chemotherapy and Pharmacology

Folfiri RegimenSaliva DataGastrointestinal OncologyMedicinePharmacology +7